默克集团Merck Group（MRK）2014年年度报告「FWB」（英文版）（266页）.pdf

1、ANNUAL REPORT 2014 DELIVERING GROWTH11,291.510,700.110,740.89,905.92014 2013 2012 2011 8,928.92010 3,253.32,964.92,723.82014 2013 2012 2011 2,545.02010 3,387.7 MERCK GROUP KEY FIGURES million 20142013Change in%Total revenues11,500.811,095.1 3.7 Sales11,291.5 10,700.15.5 Operating result(EBIT)1,762.0

2、 1,610.8 9.4 Margin(%of sales)15.6 15.1 EBITDA3,122.9 3,069.21.7 Margin(%of sales)27.728.7 EBITDA pre one-time items3,387.7 3,253.3 4.1 Margin(%of sales)30.0 30.4 Earnings per share()12.66 2.774.0 Earnings per share pre one-time items()14.60 4.394.8 Business free cash flow2,605.1 2,960.0 12.0 1 Taki

3、ng into account the share split;previous years figures have been adjusted accordingly.See“Earnings per share”in the Notes to the Consolidated Financial Statements.MERCK GROUP SALES millionMERCK GROUP EBITDA PRE ONE-TIME ITEMS millionME RCK G ROU PCompany structureMerckGroupHealthcareLife SciencePerf

4、ormance Materials Business sectorsMerck MilliporePerformance Materials BusinessesMerck SeronoConsumer HealthAllergopharmaBiosimilarsMERCK GROUP BUSINESS SECTORS AND BUSINESSESas of January 1,2015Merck is a leading company for innovative and top-quality high-tech products in healthcare,life science a

5、nd performance materials.Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients,to foster the success of customers and to help meet global challenges.Effective January 1,2015 Merck changed the structure of its financial reporting.As of the first quarter of 201

6、5,the following three business sectors will be used for reporting purposes:Healthcare comprises the Merck Serono,Consumer Health,Allergopharma and Biosimilars businesses.Life Science refers to the business of Merck Millipore.Performance Materials corresponds to the business of the same name.MERCK GR